Merck KGaA In Deal With HAPPYneuron To Offer E‑Health Solution For MS Patients (Nasdaq):
“German drug maker Merck KGaA (MKGAY.PK) announced Monday that it has entered into an agreement with HAPPYneuron, a subsidiary of SBT Group of France, in which Merck will receive an exclusive license to the company’s cognitive remediation training program for people living with multiple sclerosis [Read more…] about Merck and HAPPYneuron partner to include cognitive remediation program in Multiple Sclerosis e‑Health Solution